SOPHiA GENETICS Schedules Q2 2024 Financial Results Announcement

SOPHiA GENETICS Sets Date for Q2 2024 Financial Results

SOPHiA GENETICS SA (Nasdaq: SOPH), a leading cloud-native software company in the healthcare sector, has announced the date for its second quarter 2024 financial results release. The company will unveil its financial performance on Tuesday, August 6, 2024, before the U.S. financial markets open 1

1

Conference Call Details

Following the release of the financial results, SOPHiA GENETICS will host a conference call and webcast at 8:30 a.m. Eastern Time / 2:30 p.m. Central European Time on the same day. This call will provide an opportunity for investors and analysts to delve deeper into the company's performance and future outlook 2

2

Accessing the Conference Call

Interested parties can access the live call through various means:

1. Webcast: A live and archived webcast will be available on the company's website in the Investor Relations section 1

   1

   .
2. Telephone: Participants can join via telephone by dialing 1-877-270-2148 (US) or 1-412-902-6510 (International) 2

   2

   .

To ensure a timely connection, it is recommended that participants join at least 15 minutes before the call begins 1

1

Related Stories

SOPHiA GENETICS Showcases Advancements in Cancer Care at ESMO 2024

SOPHiA GENETICS Expands Partnership with Canadian Oncology Lab OncoHelix

SOPHiA GENETICS Unveils Groundbreaking AI-Driven Patient Stratification Research at ESMO 2024

Precision for Medicine and SOPHiA GENETICS Partner to Enhance AI-Driven Biomarker Discovery and Clinical Trials

About SOPHiA GENETICS

SOPHiA GENETICS is at the forefront of data-driven medicine, leveraging AI and machine learning to develop innovative technologies for healthcare professionals. The company's platform, SOPHiA DDM, is designed to analyze and interpret complex genomic data, assisting in clinical decision making across various medical disciplines including oncology, rare diseases, and cardiology 1

1

2

Investor Relations and Further Information

For those unable to attend the live call, a replay will be available on the company's website shortly after the conference concludes. Additionally, SOPHiA GENETICS maintains an investor relations section on their website where stakeholders can find more information about the company's financial performance and strategic initiatives 1

1

2

This upcoming financial results announcement is expected to provide valuable insights into SOPHiA GENETICS' performance in the rapidly evolving field of AI-driven healthcare solutions. As the company continues to expand its reach and refine its technologies, investors and industry observers alike will be keen to see how these developments translate into financial outcomes for the second quarter of 2024.